BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

MethylGene Inc. 

7220 Frederick-Banting
Suite 200
Montreal  Quebec  H4S 2A1  Canada
Phone: 514-337-3333 Fax: 514-337-0550


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

Merck & Co., Inc.  Antibacterials





 Company News
Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement 6/28/2013 10:47:33 AM
MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc. 6/25/2013 10:48:01 AM
MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013 9:54:26 AM
MethylGene to Present at the Jefferies and Co. 2013 Healthcare Conference 5/30/2013 10:05:19 AM
MethylGene to Present Mocetinostat Data at the 2013 American Society of Clinical Oncology Annual Meeting 5/28/2013 10:48:05 AM
MethylGene Reports First Quarter 2013 Financial Results 5/13/2013 11:03:31 AM
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ 5/9/2013 9:56:27 AM
MethylGene Presents Preclinical Data on MG516 at the American Association for Cancer Research Annual Meeting 4/8/2013 11:56:09 AM
MethylGene Reports Results of Phase 2 Trial of MGCD290 3/18/2013 12:04:55 PM
MethylGene Announces Management Changes 3/14/2013 11:51:34 AM
12345678910...